Early Detection of Anthracycline Induced Cardiotoxicity in Asymptomatic Patients with Normal Left Ventricular Systolic Function: Autonomic Versus Echocardiographic Variables

Overview

Journal Heart

Date 1999 Mar 27

PMID 10092570

Citations 28

Authors

G Tjeerdsma

M T Meinardi

W T van der Graaf

M P van den Berg

N H Mulder

H J Crijns

E G De Vries

D J van Veldhuisen

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate left ventricular dysfunction in patients who had been treated with anthracycline based chemotherapy.

Methods: Autonomic function was compared with left ventricular diastolic function in 20 asymptomatic women with normal systolic function (left ventricular ejection fraction (LVEF) > 0.50) treated for breast cancer with high dose anthracycline based chemotherapy, and 20 age matched healthy controls. Left ventricular diastolic function was assessed echocardiographically by measuring the early peak flow velocity to atrial peak flow velocity ratio, isovolumic relaxation time, and deceleration time. Heart rate variability analysis was assessed for time domain and frequency domain parameters.

Results: The mean (SD) age of the patients was 45 (7) years and the mean LVEF was 0.59 (0.06). The time interval after the end of chemotherapy was 29 (27) months. One or more diastolic variables were abnormal in 50% of the patients. Heart rate variability was abnormal in 85% of patients. Mean values of both time domain and frequency domain parameters were decreased (p < 0.05), in particular the parasympathetic indices.

Conclusions: Autonomic impairment occurs in a large proportion of asymptomatic patients with normal systolic left ventricular function after high dose anthracycline based chemotherapy. In particular, heart rate variability analysis may be a sensitive tool to identify the first signs of cardiotoxicity in these patients.

Citing Articles

Cardiovascular Autonomic Dysfunction Before and After Chemotherapy in Cancer Patients.

Yoon S, Oh J J Clin Neurol. 2024; 20(6):551-562.

PMID: 39505307 PMC: 11543394. DOI: 10.3988/jcn.2024.0221.

How to properly evaluate cardiac vagal tone in oncology studies: a state-of-the-art review.

Martinez P, Grinand M, Cheggour S, Taieb J, Gourjon G J Natl Cancer Cent. 2024; 4(1):36-46.

PMID: 39036385 PMC: 11256691. DOI: 10.1016/j.jncc.2024.02.002.

Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab.

Luna-Alcala S, Espejel-Guzman A, Lerma C, Leon P, Guerra E, Fernandez J Cardiooncology. 2024; 10(1):32.

PMID: 38812020 PMC: 11134897. DOI: 10.1186/s40959-024-00236-y.

An online home-based exercise program improves autonomic dysfunction in breast cancer survivors.

Lavin-Perez A, Collado-Mateo D, Hinojo Gonzalez C, Batista M, Mayo X, Ruisanchez Villar C Front Physiol. 2023; 14:1256644.

PMID: 37841312 PMC: 10570414. DOI: 10.3389/fphys.2023.1256644.

Assessment of short-term effects of thoracic radiotherapy on the cardiovascular parasympathetic and sympathetic nervous systems.

Wu S, Guan W, Zhao H, Li G, Zhou Y, Shi B Front Neurosci. 2023; 17:1256067.

PMID: 37732299 PMC: 10507252. DOI: 10.3389/fnins.2023.1256067.

References

Praga C, Beretta G, Vigo P, Lenaz G, Pollini C, Bonadonna G . Adriamycin cardiotoxicity: a survey of 1273 patients. Cancer Treat Rep. 1979; 63(5):827-34. View

Ishise H, Asanoi H, Ishizaka S, Joho S, Kameyama T, Umeno K . Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J Appl Physiol (1985). 1998; 84(4):1234-41. DOI: 10.1152/jappl.1998.84.4.1234. View

Akselrod S, Gordon D, Ubel F, Shannon D, Berger A, Cohen R . Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981; 213(4504):220-2. DOI: 10.1126/science.6166045. View

McKillop J, Bristow M, Goris M, Billingham M, Bockemuehl K . Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am Heart J. 1983; 106(5 Pt 1):1048-56. DOI: 10.1016/0002-8703(83)90651-8. View

Perry G, Helmcke F, Nanda N, Byard C, Soto B . Evaluation of aortic insufficiency by Doppler color flow mapping. J Am Coll Cardiol. 1987; 9(4):952-9. DOI: 10.1016/s0735-1097(87)80254-1. View

Zarich S, ARBUCKLE B, Cohen L, Roberts M, Nesto R . Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol. 1988; 12(1):114-20. DOI: 10.1016/0735-1097(88)90364-6. View

Kuecherer H, Ruffmann K, Schaefer E, Kuebler W . Doppler echocardiographic assessment of left ventricular filling dynamics in patients with coronary heart disease and normal systolic function. Eur Heart J. 1988; 9(6):649-56. DOI: 10.1093/oxfordjournals.eurheartj.a062556. View

Spain M, Smith M, Grayburn P, Harlamert E, DeMaria A . Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol. 1989; 13(3):585-90. DOI: 10.1016/0735-1097(89)90597-4. View

Marchandise B, Schroeder E, Bosly A, Doyen C, Weynants P, Kremer R . Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J. 1989; 118(1):92-8. DOI: 10.1016/0002-8703(89)90077-x. View

10.

Binkley P, Nunziata E, Haas G, Nelson S, Cody R . Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol. 1991; 18(2):464-72. DOI: 10.1016/0735-1097(91)90602-6. View

11.

Steinherz L, Steinherz P, Tan C, Heller G, Murphy M . Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA. 1991; 266(12):1672-7. View

12.

Stoddard M, Seeger J, Liddell N, Hadley T, Sullivan D, Kupersmith J . Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol. 1992; 20(1):62-9. DOI: 10.1016/0735-1097(92)90138-d. View

13.

Taylor R, Waggoner A . Doppler assessment of left ventricular diastolic function: a review. J Am Soc Echocardiogr. 1992; 5(6):603-12. DOI: 10.1016/s0894-7317(14)80326-x. View

14.

Bonadonna G, Zambetti M, Valagussa P . Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results. JAMA. 1995; 273(7):542-7. View

15.

de Graaf H, Willemse P, Sleijfer D, De Vries E, van der Graaf W, Beukema J . Effective conditioning regimen for premenopausal patients with advanced breast cancer. Anticancer Res. 1994; 14(6B):2799-804. View

16.

Eaton G, Cody R, Nunziata E, Binkley P . Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure. Circulation. 1995; 92(3):555-61. DOI: 10.1161/01.cir.92.3.555. View

17.

Grassi G, Seravalle G, Cattaneo B, Lanfranchi A, Vailati S, Giannattasio C . Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995; 92(11):3206-11. DOI: 10.1161/01.cir.92.11.3206. View

18.

Tuininga Y, Crijns H, Brouwer J, van den Berg M, Man int Veld A, Mulder G . Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients. Circulation. 1995; 92(12):3415-23. DOI: 10.1161/01.cir.92.12.3415. View

19.

Postma A, Kengen R, Elzenga N, Schraffordt Koops H, Kamps W . Late cardiotoxicity after treatment for a malignant bone tumor. Med Pediatr Oncol. 1996; 26(4):230-7. DOI: 10.1002/(SICI)1096-911X(199604)26:4<230::AID-MPO2>3.0.CO;2-K. View

20.

Cohen G, Pietrolungo J, Thomas J, Klein A . A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol. 1996; 27(7):1753-60. DOI: 10.1016/0735-1097(96)00088-5. View